Regulations.gov document
Labeling Requirements for Approved or Conditionally Approved New Animal Drugs
Proposed Rule · FDA-2023-N-5160 · posted Mar 12, 2024
Key facts
| Document ID | FDA-2023-N-5160-0001 |
|---|---|
| Title | Labeling Requirements for Approved or Conditionally Approved New Animal Drugs |
| Document type | Proposed Rule |
| Subtype | Notice of Proposed Rulemaking (NPRM) |
| Agency | FDA |
| Docket | FDA-2023-N-5160 |
| Posted | Mar 12, 2024 |
| Federal Register citation | 89 FR 18262 |
| FR document number | 2024-04840 |
| CFR | 21 CFR Parts 201, 500, 501, 510, 514, and 516 |
| Comment period opens | Mar 12, 2024 |
| Comments due | Aug 10, 2024 |
| Effective date | Mar 12, 2024 |
At a glance
- 10–99 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: